|
⚲
|
| Keyboard |
| Heron Elaine J
✚
|
|
|---|---|
| CIK # | 0001235471 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001235471] | |
| 4 | [0001235471] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Heron Elaine J | |
| Palvella Therapeutics Inc | |
| NABI Biopharmaceuticals | |
| BioMarin Pharmaceutical Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Palvella Therapeutics Inc PVLA
Common Stock
|
2026-02-27 | Buy | 2,400 | $125.00 | 300,000 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-11-17 | Buy | 16,783 | $0.41 | 6,881 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-11-17 | Buy | 23,217 | $0.39 | 9,055 |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-06-13 | Grant | 95,400 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-06-13 | Grant | 16,000 | $0.00 | |
|
Palvella Therapeutics Inc PVLA
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-10 | Grant | 12,350 | $0.00 | |
|
Palvella Therapeutics Inc PVLA
Stock Option (right to buy) · derivative
|
2024-12-13 | Grant | 24,700 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2024-06-11 | Grant | 95,400 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-06-11 | Grant | 16,000 | $0.00 | |
|
BioMarin Pharmaceutical Inc BMRN
Stock Option (Right to Buy Common Stock) · derivative
|
2024-06-03 | Option exercise | 5,047 | $0.00 | |
|
BioMarin Pharmaceutical Inc BMRN
Common Stock
|
2024-06-03 | Tax withheld | 4,168 | $76.41 | 318,477 |
|
BioMarin Pharmaceutical Inc BMRN
Common Stock
|
2024-06-03 | Option exercise | 5,047 | $63.10 | 318,466 |
|
BioMarin Pharmaceutical Inc BMRN
Common Stock
|
2024-05-21 | Grant | 4,720 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-06-26 | Grant | 6,922 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2023-06-26 | Grant | 41,510 | $0.00 | |
|
BioMarin Pharmaceutical Inc BMRN
Common Stock
|
2023-05-23 | Grant | 4,190 | $0.00 | |
|
BioMarin Pharmaceutical Inc BMRN
Common Stock
|
2023-05-12 | Option exercise | 8,500 | $67.81 | 576,385 |
|
BioMarin Pharmaceutical Inc BMRN
Common Stock
|
2023-05-12 | Tax withheld | 6,137 | $93.93 | 576,448 |
|
BioMarin Pharmaceutical Inc BMRN
Stock Option (Right to Buy Common Stock) · derivative
|
2023-05-12 | Option exercise | 8,500 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2022-08-25 | Grant | 88,448 | $0.00 | |
| showing 20 of 62 most recent transactions | |||||